# Bluesail Surgical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/bluesail-surgical

- Industry: Medical Devices & Equipment
- Headquarters: Shanghai, China
- Website: www.bluesailsurgical.com
- Latest round: Series A (Feb 9, 2026)
- Investors on record: 1

## About

Bluesail Surgical Co., Ltd., located in Shanghai, specializes in providing advanced surgical instruments and technologies aimed at enhancing surgical procedures through innovation and precision.Founded in 2021, Bluesail Surgical Co., Ltd. operates out of Shanghai, China, focusing on developing surgical solutions. The company is involved in its first deal, which took place on February 9, 2026, when it raised Series A+ funding led by Proxima Ventures. No significant changes in business operations have been reported since its inception.Bluesail Surgical specializes in advanced surgical instruments and technologies designed to enhance minimally invasive and non-invasive procedures. Their core offerings include state-of-the-art devices that incorporate intelligent control systems, optimized designs, and innovative cleaning technologies, such as the pulse gas-liquid flow cleaning system and unique W-bottom anti-fog film technology. These products address critical challenges in surgical settings, including reducing complications, improving precision, and providing better prognoses for patients. The company serves a diverse client base that includes hospitals, surgical centers, and healthcare providers across multiple geographical markets, particularly in regions with advanced healthcare infrastructure.The revenue structure of Bluesail Surgical is primarily derived from direct sales of its surgical instruments and technologies to healthcare facilities. This includes transactions with hospitals and surgical centers that require sophisticated equipment for various procedures, reflecting the innovative nature of their product offerings. The company builds enduring partnerships with its clients, contributing to a stable revenue stream.Bluesail Surgical plans to utilize the Series A+ funding raised in February 2026 for research and development investments, capacity expansion, and market development. The company is currently focused on designing and launching new products aimed at enhancing surgical precision. Specific markets targeted for expansion include regions with increasing demand for advanced surgical technologies, which will be pursued over the coming years.

## Funding rounds

- Series A, Feb 9, 2026 — Proxima Ventures

## Investors

- Proxima Ventures (https://capitalatlas.ai/funds/proxima-ventures) — Series A